pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 10·1 min read
save

Study finds doctors still accept pharma gifts and speaking fees despite ongoing debate

Sep 10, 2026·read at STAT ↗Negative

A new analysis surveyed 283 physicians who had previously responded as part of a 2011 study of more than 1,300 medical students and residents. The researchers compared the recent responses with the earlier data to assess changes in physician interactions with drug companies.

The results show that doctors continue to accept free meals, drug samples, gifts and speaking fees from pharmaceutical representatives. Acceptance rates have remained stable over the years, indicating that the practice persists despite public criticism.

The authors note that the issue remains contentious, with ongoing debate about whether such largesse influences prescribing behavior. The study suggests that existing policies have not significantly altered physician behavior.

The findings highlight the need for continued monitoring and possible regulatory attention to ensure that physician-pharma relationships do not compromise patient care.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The gifts from pharma companies that keep on giving”

read at STAT ↗
465 words · retrieved Sep 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVARTIS2ASTRAZENECAGILEADNOVONovo Nordisk Inc
topics
COPDOncology

related stories

  • Sep 10STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and moreSTAT
  • Sep 10STAT+: Cancer medicines remain in short supply across the U.S., survey findsSTAT
  • Sep 9STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and moreSTAT
  • 4d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Oct 1Chutes & Ladders—Bayer taps new chief medical officer; Cantor appointed PhRMA CEOFierce Biotech